Technologies used in Parkinson’s disease: a meta-analysis of their effect on health-related quality of life

Comprehensive Summary

Fidan investigates whether technological interventions improve health-related quality of life (HRQoL) for those with Parkinson's Disease (PD). While past research has been inconclusive, further meta-analysis on randomized control trials was essential to better understand the efficacy technology like wearables, digital tools and rehabilitation systems, and device facilitated therapies. Computing with the mean effect sizes with fixed-effects and random-effects models, moderator analyses are performed to determine benefits by time point, technology type, and scale. The study analysis determined that technology has a significantly positive effect on HRQoL, and the magnitude of improvement was dependent on what technology was used. Short and long term follow up also impacted the size of the effect. Standardizing HRQoL measurement tools across trials provides researchers with better ways to determine the efficacy of technology interventions for PD. Overall, while technology based interventions are promising and beneficial, but further research should better quantify the efficacy of technology across specific patient groups.

Outcomes and Implications

Medically, these findings would be able to enhance patient's quality of life, especially when added as a supplement for traditional treatments. For this, clinicians would need to experiment with different technology, especially since each person would respond to specific technology differently. Standardizing HRQoL measurements would also make future studies more reliable. This study would expand access to care especially the addition of other ways to treat the symptoms of PD. Finally, this study promotes the importance of continued investment and innovation in digital devices and other AI based treatments for conditions like Parkinson's Disease.